Molecular imaging of protein kinases
Open Access
- 1 February 2008
- journal article
- review article
- Published by Taylor & Francis in Cell Cycle
- Vol. 7 (3) , 314-317
- https://doi.org/10.4161/cc.7.3.5409
Abstract
Protein kinases are important regulators of signal-transduction pathways. Dysregulated kinase activity is observed in a variety of human diseases such as cancer, making them targets for the development of molecular therapies. Identification of new drugs is greatly aided by molecular imaging tools which enable real time, non-invasive, dynamic and quantitative imaging of kinase activity in vivo. We have recently described a new reporter platform based on conformation dependent complementation of firefly luciferase to monitor serine/threonine kinase (Akt) activity. The reporter system provides unique insights into the pharmacokinetics and pharmacodynamics of drugs that modulate kinase activity in living subjects and also provide a platform for cell based high-throughput drug screening for modulators of kinase activity.Keywords
This publication has 25 references indexed in Scilit:
- Fluorescent Indicators for Akt/Protein Kinase B and Dynamics of Akt Activity Visualized in Living CellsJournal of Biological Chemistry, 2003
- A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase CThe Journal of cell biology, 2003
- Issues and progress with protein kinase inhibitors for cancer treatmentNature Reviews Drug Discovery, 2003
- Monitoring Protein−Protein Interactions Using Split Synthetic Renilla Luciferase Protein-Fragment-Assisted ComplementationAnalytical Chemistry, 2003
- Advances in In Vivo Bioluminescence Imaging of Gene ExpressionAnnual Review of Biomedical Engineering, 2002
- Imatinib. Novartis.2002
- Imaging of light emission from the expression of luciferases in living cells and organisms: a reviewLuminescence, 2002
- Genetically encoded reporters of protein kinase A activity reveal impact of substrate tetheringProceedings of the National Academy of Sciences, 2001
- Biological activity of tyrosine kinase inhibitors: novel agents for psoriasis therapy.2001
- Oncogenic kinase signallingNature, 2001